Back to search

Conflict of Interest in the Debate over Calcium-Channel Antagonists

Data up to Jan 2025

Published1998
Citations641
References39

Total Citations Per Year

Abstract

References (39)

Categorical Data Analysis

1991 • 9,374 citations

Analysis of Binary Data

2008 • 2,760 citations

Nifedipine

1995 • 1,175 citations

The Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies

1995 • 970 citations

Statistical Inference under Order Restrictions (The Theory and Application of Isotonic Regression)

1973 • 886 citations

Scientific versus commercial sources of influence on the prescribing behavior of physicians

1982 • 584 citations

The Effects of Pharmaceutical Firm Enticements on Physician Prescribing Patterns

1992 • 394 citations

Calcium-channel blockade and incidence of cancer in aged populations

1996 • 340 citations

Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary

1994 • 332 citations

Long‐Term Survival and Use of Antihypertensive Medications in Older Persons

1995 • 277 citations

Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old

1996 • 226 citations

The risk of myocardial infarction associated with antihypertensive drug therapies

1995 • 192 citations

Analysis of Binary Data.

1990 • 112 citations

Choice of initial therapy for hypertension

1996 • 54 citations

Spinning the risks and benefits of calcium antagonists

1995 • 38 citations

FDA gives calcium channel blockers clean bill of health but warns of short-acting nifedipine hazards.

1996 • 36 citations

Should Dihydropyridines Be Used as First-Line Drugs in the Treatment of Hypertension?

1995 • 31 citations

The unnecessary controversy

1996 • 30 citations

Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives

1990 • 20 citations

Critical appraisal of recent studies on nifedipine and other calcium channel blockers in coronary artery disease and hypertension

1996 • 19 citations

Calcium channel blockers and myocardial infarction. A hypothesis formulated but not yet tested

1995 • 18 citations

NEWS

1996 • 18 citations

Prognosis of patients with unstable angina or acute myocardial infarction treated with calcium channel antagonists

1996 • 16 citations

Calcium channel blockers and myocardial infarction.

1996 • 15 citations

Nifedipine in acute coronary syndromes: Furberg's refrain revisited

1996 • 11 citations

Calcium antagonists should continue to be used for first-line treatment of hypertension

1995 • 11 citations

Antagonism to calcium antagonists

1996 • 10 citations

FDA gives calcium channel blockers clean bill of health but warns of short-acting nifedipine hazards

1996 • 9 citations

Bayer accused of disinformation

1995 • 6 citations

Should dihydropyridines be used as first-line drugs in the treatment of hypertension? The con side

1995 • 5 citations

Long-term safety of calcium antagonists: Reassessment of the Furberg hypothesis

1996 • 4 citations

Meta-Analysis and Bouillabaisse

1996 • 3 citations

Calcium–channel blockers and risk of myocardial infarction—more hype than harm

1995 • 2 citations

Dear doctor ... regarding calcium channel blockers

1996 • 2 citations

Do calcium antagonists cause cancer?

1996 • 1 citations

Untitled

1996 • 1 citations

Dear Doctor... Regarding Calcium Channel Blockers-Reply

1996 • 1 citations

Dear Doctor... Regarding Calcium Channel Blockers-Reply

1996 • 1 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...